Net sales grew 4.7% year-over-year, driven by Life Science and semiconductor-related products, while operating profit fell 22.9% due to higher costs. The company revised its full-year outlook upward and announced a major cement business divestiture.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.